Close Menu

At the CED Life Sciences Conference this week, Sanofi CEO Chris Viehbacher said that researchers who work for big pharma tend to be the least innovative, reports Pharmalot's Ed Silverman. The best scientists, Viehbacher said, work for small biotechs — that's why Sanofi is reducing its internal research capacity and partnering with outside companies, biotechs, and universities to get R&D done.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

Nature News writes that additional details about the UK plan for an agency to support high-risk, high-reward science are needed.

The New York Times reports that the US Food and Drug Administration has authorized Johnson & Johnson's SARS-CoV-2 vaccine.

The Wall Street Journal writes new studies are giving glimpses into the origins of SARS-CoV-2.

In PLOS this week: analysis of Plasmodium population structure, qPCR assay to diagnose scabies, and more.